FDA-approved digital therapeutic for amblyopia. Launching later this year.

My child has amblyopia,
what do we do?

Mother and child scroll down

Why addressing amblyopia is important

It leads to missing out in school, sports, work, and everyday life.
It can even cause permanent vision loss.

Developed with leading pediatric
ophthalmologists and neuroscientists

Developed with leading pediatric ophthalmologists and neuroscientists

My child has amblyopia
Why it’s important
Doctor’s opinion

Evidence-Based Science

Luminopia One is a digital therapeutic built on years of cutting-edge science. Our neuroscience-based approach works by presenting TV and movie content differently to each eye within a kid-friendly virtual reality (VR) headset. Thanks to powerful neural plasticity, this rebalancing approach strengthens visual processing, promotes weaker eye usage, and encourages both eyes to work together properly!

At Luminopia, we place a strong emphasis on rigorous clinical research to show that our products are safe and effective for children. To date, we have conducted several clinical trials on Luminopia One in collaboration with leading hospitals and research institutions across the United States. These studies, including a prospective, randomized controlled trial, have demonstrated the potential for Luminopia One to be an engaging and effective at-home therapy for amblyopia. Luminopia One has been approved by the FDA for prescription use, and is indicated for improvement in visual acuity in amblyopia patients aged 4-7.

View supporting literature

Our Scientific Advisors

Peter J. McDonnell, MD

Director of The Wilmer Eye Institute

David G. Hunter, MD, PhD

Ophthalmologist-in-Chief, Boston Children’s Hospital

Gil Binenbaum, MD, MSCE

Chief of Division of Ophthalmology, Children's Hospital of Philadelphia

Marguerite McDonald, MD, FACS

Clinical Professor of Ophthalmology, New York University Langone Medical Center

Mark Bear, PhD

Professor of Neuroscience at MIT’s Picower Institute for Learning and Memory

Board of Directors

Robert Langer, ScD

Institute Professor at MIT; Co-Founder of Moderna; Most cited engineer in history

Michelle Kydd Lee

Chief Innovation Officer for Creative Artists Agency; Co-Founder of TIME’S UP

Jeffrey Dunn

Executive Chairman at Sesame Workshop; Former COO of Nickelodeon Networks

Mark Jacobstein

Chief Business Officer at Immunai; Former Chief User Engagement Officer at Guardant Health

Fun and Easy

Luminopia One works by modifying popular TV shows and movies into therapeutic visual stimuli within a VR headset. With a broad library of beloved content available, all you have to do is pick a video and enjoy as we take care of the rest!

Our Media Partners

Easy to use interface

Our simple software application places you into an immersive world that makes it easy to select content and receive therapy.

Real-time insights

In addition to the therapy, our cloud-based online platform provides insights into your usage, helping you stay on track!